MedTrace Logo

DCB Compared Stenting in Popliteal Lesions

NCT03739580 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-11-14

No results posted yet for this study

Summary

This is a randomized prospective study aiming to compare drug-coated balloons and stent deployment in Popliteal atherosclerotic occlusive lesions.

Conditions

  • Popliteal Stenosis
  • Popliteal Artery Occlusion
  • Diabetes

Interventions

DEVICE

DCB angioplasty (Orchid, Acotec Scientific Co. Ltd.)

for popliteal stenosis/occlusive lesions, randomised received DCB or Stent deployment.

DEVICE

Stent (Maris,Medtronic.USA or Sinus/Supera, Germany)

for popliteal stenosis/occlusive lesions, randomised received DCB or Stent deployment.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Yongquan Gu, M.D. · Xuanwu hospital CMU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2018-12-01
Completion
2019-09-01
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03739580 on ClinicalTrials.gov